Skip directly to search Skip directly to A to Z list Skip directly to navigation Skip directly to page options Skip directly to site content

Human Genome Epidemiology Literature Finder|Home|PHGKB

Human Genome Epidemiology Literature Finder


Last data update: Dec 13, 2024. (Total: 234352Documents)
   dataset        GWAS Only
Filtered By:

Previous    

Records 1 - 5 (of 5 Records)

Query Trace: Disease Progression and SRD5A2[original query]
Inherited variation in hormone-regulating genes and prostate cancer survival.
Clinical cancer research : an official journal of the American Association for Cancer Research 2007 Sep 13 (17): 5156-61.
Lindström Sara, Adami Hans-Olov, Bälter Katarina Augustsson, Xu Jianfeng, Zheng S Lilly, Stattin Pär, Grönberg Henrik, Wiklund Fredr
The SRD5A2 V89L polymorphism is associated with severity of disease in men with early onset prostate cancer.
The Prostate 2008 Dec 68 (16): 1798-805.
Scariano John K, Treat Eric, Alba Frances, Nelson Harold, Ness Scott A, Smith Anthony
Genetic variation of genes involved in dihydrotestosterone metabolism and the risk of prostate cancer.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2010 Jan 19 (1): 1.
Setlur Sunita R, Chen Chen X, Hossain Ruhella R, Ha Jung Sook, Van Doren Vanessa E, Stenzel Birgit, Steiner Eberhard, Oldridge Derek, Kitabayashi Naoki, Banerjee Samprit, Chen Jin Yun, Schäfer Georg, Horninger Wolfgang, Lee Charles, Rubin Mark A, Klocker Helmut, Demichelis Frances
Molecular markers in key steroidogenic pathways, circulating steroid levels, and prostate cancer progression.
Clinical cancer research : an official journal of the American Association for Cancer Research 2013 Feb 19 (3): 699-709.
Lévesque Éric, Huang Shu-Pin, Audet-Walsh Étienne, Lacombe Louis, Bao Bo-Ying, Fradet Yves, Laverdière Isabelle, Rouleau Mélanie, Huang Chao-Yuan, Yu Chia-Cheng, Caron Patrick, Guillemette Chant
A common germline variant in CYP11B1 is associated with adverse clinical outcome of treatment with abiraterone or enzalutamide.
Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie 2023 11 169 115890.
Stefan A J Buck, Marinda Meertens, Frederiek M F van Ooijen, Esther Oomen-de Hoop, Evert de Jonge, Marieke J H Coenen, Andries M Bergman, Stijn L W Koolen, Ronald de Wit, Alwin D R Huitema, Ron H N van Schaik, Ron H J Mathijss
TOP